The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Recent News

Growth is on the Horizon as Biologics Consulting continues Partnership with The Chase Group to Expand Leadership Team

April 8, 2021
The Chase Group is pleased to announce their continued partnership with Biologics Consulting after being retained to execute a search for a Business Development Lead…. Continue Reading →

Ferrer Partners with The Chase Group to Identify US Business Development Leader

March 18, 2021
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

March 10, 2021
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →

Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group

March 3, 2021
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained… Continue Reading →

Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group

January 29, 2021
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,… Continue Reading →

Alexza Pharmaceuticals Continues Partnership with The Chase Group to Seek Clinical Operations Leader

January 27, 2021
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →

The Chase Group Retained by Checkmate Pharmaceuticals to Identify Head of Regulatory Affairs

January 15, 2021
Checkmate Pharmaceuticals has once again partnered with The Chase Group to continue building its team of life sciences entrepreneurs who are devoted to discovering and… Continue Reading →

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →

The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics

January 5, 2021
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… Continue Reading →

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

November 24, 2020
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical… Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.